MSM, or methylsulfonylmethane, is an organic sulphur compound sold for joint pain, usually combined with glucosamine. The evidence is thin: a meta-analysis of knee osteoarthritis found three eligible randomised trials totalling 326 patients, two showing statistically significant but not clinically relevant pain reduction, with the pooled result non-significant. A systematic review concluded there was no definitive evidence to support its use. It appears well tolerated, and it is mostly bought unknowingly inside combination products.
How MSM compares with the better-evidenced options is set out in PhysioHub’s assessment of supplement evidence.
Ranked by how much each one shapes an honest answer to the question of whether MSM is worth taking.
| Finding | What it establishes | Strength |
|---|---|---|
| 1. Three small trials | 326 patients in total across the meta-analysis | The whole evidence base |
| 2. Pooled result non-significant | No reliable pain benefit when combined | Direct finding |
| 3. Not clinically relevant | The two positive trials found small effects | Direct finding |
| 4. Dose not established | Reviewers called for work to identify optimum dosing | An open question after years on sale |
| 5. Usually in a combination | Bought without a specific decision to take it | Practical observation |
What is unusual about MSM is that its basics remain unsettled. For most supplements the argument is about how large the effect is; here the dose, the duration and whether there is an effect at all are all still open questions after decades of availability.
This is a documentary review of the published trial evidence rather than advice about what to take. Five findings were selected because between them they describe the whole state of knowledge on this supplement, which is not large.
The sources read were a meta-analysis of the related nutritional supplements DMSO and MSM in knee osteoarthritis; a systematic review of DMSO and MSM in the treatment of osteoarthritis, quality-assessed in the NHS Database of Abstracts of Reviews of Effects; and a pilot randomised trial of MSM in knee osteoarthritis pain. Evidence checked in August 2026.
The honest position is that this is a short page because there is not much to report. Where you see confident claims about MSM rebuilding cartilage, reducing inflammation by a stated percentage or requiring a specific dose, those claims are not coming from this evidence base, because this evidence base does not contain them.
No prices or brands are named, because retail costs could not be verified for this review.
Check whether you are already taking it. MSM appears in a large share of combination joint products, so the first question is often whether this is a decision you have already made without noticing.
Separate safety from efficacy. MSM appears well tolerated at the doses studied, which is a reason it is unlikely to harm you rather than a reason it will help.
Do not read absence of evidence as evidence of absence. Three small trials is too little to conclude that MSM does nothing. It is also too little to conclude that it does something.
Consider what it is competing with. Omega-3 and curcumin both have substantially more evidence, and exercise has more than either.
If you try it, test it properly. Take it alone rather than in a combination, at a consistent dose, for eight to twelve weeks, then stop and compare.
What was found
A meta-analysis of MSM and the related compound DMSO in knee osteoarthritis identified three randomised controlled trials of MSM eligible for inclusion, with 326 patients in total. All three were assessed as being of high methodological quality.
Why that number matters
For comparison, the GAIT trial of glucosamine and chondroitin randomised 1,583 people on its own. The entire MSM literature is a fifth of that, spread across three separate studies with different doses and durations.
What it means
A small evidence base produces wide uncertainty. It is entirely possible for a real, modest effect to exist and not be detectable at this sample size, and equally possible for the positive signals to be noise.
Limits and cautions
An earlier systematic review found six studies meeting its broader inclusion criteria and drew no definitive conclusions from them either.
Why it ranks first
Everything else about MSM has to be read in the light of how little has been done, and that context is usually missing from what is written about it.
What was found
When the three trials were combined, the meta-analysis confirmed a non-significant reduction in pain. Pooling the studies did not produce a reliable effect.
Why pooling matters
Combining trials increases the sample size and the ability to detect a genuine effect. When pooling makes a result less convincing rather than more, that is informative: the individual positive findings were not consistent enough to survive being put together.
What it does not establish
A non-significant pooled result with 326 patients does not prove MSM has no effect. It establishes that no reliable effect has been demonstrated, which is a weaker and more accurate statement.
Limits and cautions
The three trials used different doses and different durations, which makes pooling them a somewhat rough exercise and is itself a consequence of the dosing question never having been settled.
Why it ranks second
It is the single most direct answer to the question people are asking, and it is the finding most often omitted from articles recommending MSM.
What was found
Two of the three trials in the meta-analysis demonstrated a statistically significant reduction in pain compared with controls, and the reviewers described those reductions as not clinically relevant.
What the distinction means
Statistical significance means the difference is unlikely to be chance. Clinical relevance means the difference is large enough for a person to notice and value. A trial can find the first without the second, particularly on continuous pain scales, and this appears to be what happened here.
Why it matters when reading claims
Marketing material routinely quotes the statistical significance and omits the reviewers’ assessment of size. Reading that MSM significantly reduced pain in clinical trials is technically accurate and misses the point that the reduction was judged too small to matter.
The related trial
A pilot trial of MSM at 3g twice daily for twelve weeks reported improvements in pain and physical function without major adverse events, and its authors stated that the benefits and safety of MSM in managing osteoarthritis could not be confirmed from a pilot study.
Why it ranks third
It explains how honest trial results become misleading claims, which is the mechanism at work in most of what is written about this supplement.
What is unresolved
Reviewers of both the systematic review and the meta-analysis called for further research to clarify optimum dosage, efficacy and safety, and specifically for trials to identify the optimum dose of MSM.
What the trials used
Doses varied. The pilot trial used 3g twice daily, giving 6g per day, over twelve weeks. Products on sale commonly provide considerably less, particularly in combination formulas.
Why it matters
An unsettled dose makes the whole literature harder to interpret, because a negative trial could reflect an ineffective compound or an insufficient dose, and there is no way to tell which. It also means a person cannot know whether the product they bought resembles anything that was studied.
Limits and cautions
Long-term safety at higher doses is not well characterised either, since the trials were short. Reported side effects at studied doses are mild and mostly gastrointestinal.
Why it ranks fourth
It is why the question stays open rather than being resolved, and it is unusual for a supplement that has been widely sold for this long.
What happens in practice
MSM appears in a large share of joint supplement formulas, most often alongside glucosamine and chondroitin. Many people taking it did not choose it; they chose a joint supplement, and MSM was in it.
Why that is a problem
Combination products typically contain several ingredients, none necessarily at a dose that was tested. They also make it impossible to attribute any effect to any component, so a person who feels better cannot know why and a person who does not cannot know what failed.
What to do about it
If you want to know whether MSM does anything for you, take it alone at a consistent dose for eight to twelve weeks, then stop for four weeks and compare. That is the only informative way to test any supplement, and combination products make it impossible.
The wider point
The glucosamine it is usually paired with has been tested thoroughly and did not beat placebo in the largest trial, so a combination of the two is a product with one poorly evidenced ingredient and one well evidenced as ineffective.
Why it ranks fifth
It is a practical observation rather than a research finding, and it explains why so many people are taking a supplement they have never evaluated.
| Supplement | Total trial participants | Pooled effect on pain | Dose established |
|---|---|---|---|
| MSM | 326 across three trials | Non-significant | No |
| Glucosamine and chondroitin | 1,583 in one trial alone | No significant benefit over placebo | Yes |
| Curcumin | Many trials, variable quality | Positive, low certainty | Varies by formulation |
| Omega-3 | Multiple trials in rheumatoid arthritis | Positive for pain and stiffness | Yes, around 2.7g EPA plus DHA |
MSM is the least studied item in this comparison and the only one where the appropriate dose is still an open question. That combination is why it sits at the bottom of any evidence-ranked list of joint supplements.
If you are considering starting MSM, the evidence does not support it, and omega-3 or curcumin have considerably more behind them depending on which condition you have.
If you take a combination joint supplement, check the label. You may be taking MSM without having decided to, alongside glucosamine that the largest trial found no better than placebo.
If you take MSM and believe it helps, it appears well tolerated at studied doses, so continuing is a reasonable personal decision. Testing it by stopping for four weeks is the only way to know.
If you want to test it properly, take it on its own at a consistent dose rather than inside a combination, for eight to twelve weeks, then stop.
If MSM is the only thing you are doing for an arthritic joint, that is the situation worth changing, since exercise has an effect size no supplement on the market has demonstrated.
The belief worth addressing here is not that MSM works. Very few people arrive convinced of that. It is the quieter assumption that a supplement on sale in a pharmacy must have been shown to do something, and that a combination of several ingredients must be better than one.
Neither holds. Supplements are regulated as foods rather than medicines in the UK, so a product reaches the shelf without demonstrating efficacy, and a combination formula is usually several small doses rather than several effective ones. The practical consequence is a bathroom cabinet with four bottles in it, a monthly outlay, and no way for the person to tell what any of it is doing.
The conversation that helps is usually about what has not been tried rather than what has. Someone taking a combination joint supplement for eighteen months has typically never had the knee assessed, never had a loading programme, and never been told that the effect size for strengthening in osteoarthritis is larger than anything in the bottle. If you are unsure whether what you have is the kind of problem that responds to loading, a free discovery and triage call will tell you in ten minutes.
Does MSM help joint pain?
The evidence does not establish that it does. A meta-analysis of three randomised trials totalling 326 patients with knee osteoarthritis found a non-significant pooled reduction in pain, and the two individual trials showing statistical significance were assessed as showing reductions that were not clinically relevant.
What is MSM and what does it do?
Methylsulfonylmethane is an organic sulphur compound found naturally in small amounts in some foods and sold as a supplement for joint pain. Proposed mechanisms involve supplying sulphur for connective tissue and reducing inflammation, and neither has been convincingly demonstrated to produce a clinical benefit in the available trials.
What is the right dose of MSM for joints?
It has not been established. Reviewers of the available evidence specifically called for trials to identify the optimum dose. One pilot trial used 3g twice daily for twelve weeks, and many products on sale contain considerably less, particularly in combination formulas.
Is MSM safe?
It appears well tolerated at the doses studied, with reported side effects mild and mostly gastrointestinal. The trials were short, so long-term safety is not well characterised. As with any supplement, tell your pharmacist what you are taking if you are on prescribed medication.
Should I take MSM with glucosamine?
The two are commonly sold together, and glucosamine did not beat placebo for knee pain in the largest trial conducted, while MSM has a non-significant pooled result across three small trials. Combination products also make it impossible to tell which ingredient is responsible for anything you notice.
How long does MSM take to work?
The trials ran for around twelve weeks, so that is the sensible period over which to judge it. Taking it on its own rather than in a combination, then stopping for four weeks afterwards, is the only way to distinguish an effect from the natural fluctuation of joint pain.
Is there anything better than MSM for joint pain?
Yes. For rheumatoid arthritis, omega-3 has consistent evidence at around 2.7g of combined EPA and DHA daily. For knee osteoarthritis, curcumin has more positive trials, though the review quality is low. More significantly, therapeutic exercise is the core NICE recommendation for osteoarthritis and has a considerably larger effect than any supplement studied.
PhysioHub – Empowerment through Evidence-Based Education.
Every body is different. Book a thorough assessment and get advice that is specific to you and your goals.
Book an Appointment